Reproducing prolonged time to peak bisoprolol concentration by PBPK modeling with lysosomal trapping in enterocytes
- PMID: 34927374
- PMCID: PMC8752105
- DOI: 10.1002/psp4.12756
Reproducing prolonged time to peak bisoprolol concentration by PBPK modeling with lysosomal trapping in enterocytes
Conflict of interest statement
The authors declared no competing interests for this work.
References
-
- Macwan JS, Fraczkiewicz G, Bertolino M, Krüger P, Peters SA. Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: the case of bisoprolol. CPT Pharmacometrics Syst Pharmacol. 2021;10(6):622‐632. - PMC - PubMed
-
- Hansmann S, Darwich A, Margolskee A, Aarons L, Dressman J. Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models. J Pharm Pharmacol. 2016;68(12):1501‐1515. - PubMed
-
- Peters SA, Hultin L. Early identification of drug‐induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration‐time profiles in rat. J Pharmacokinet Pharmacodyn. 2008;35(1):1‐30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
